Hasholzner U - Search Results

1

Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.

Hasholzner U, Stieber P, Zimmermann A, Burges A, Hofmann K, Schmitt UM, Schmeller N, Schalhorn A. Hasholzner U, et al. Anticancer Res. 1999 Jul-Aug;19(4A):2415-20. Anticancer Res. 1999. PMID: 10470168

2

CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.

Hasholzner U, Stieber P, Reiter W, Zimmermann A, Hofmann K, Schalhorn A. Hasholzner U, et al. Anticancer Res. 1999 Jul-Aug;19(4A):2477-80. Anticancer Res. 1999. PMID: 10470177

3

BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?

Mahnert B, Tauber S, Kriegmair M, Schmitt UM, Hasholzner U, Reiter W, Hofmann K, Schmeller N, Stieber P. Mahnert B, et al. Among authors: hasholzner u. Anticancer Res. 1999 Jul-Aug;19(4A):2615-9. Anticancer Res. 1999. PMID: 10470204

4

Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.

Stieber P, Dienemann H, Hasholzner U, Müller C, Poley S, Hofmann K, Fateh-Moghadam A. Stieber P, et al. Among authors: hasholzner u. Eur J Clin Chem Clin Biochem. 1993 Oct;31(10):689-94. doi: 10.1515/cclm.1993.31.10.689. Eur J Clin Chem Clin Biochem. 1993. PMID: 7507359

5

Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases.

Stieber P, Dienemann H, Hasholzner U, Fabricius PG, Schambeck C, Weinzierl M, Poley S, Samtleben W, Hofmann K, Meier W, et al. Stieber P, et al. Among authors: hasholzner u. Int J Biol Markers. 1994 Apr-Jun;9(2):82-8. doi: 10.1177/172460089400900204. Int J Biol Markers. 1994. PMID: 7523546 Clinical Trial.

6

Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.

Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A. Hasholzner U, et al. Anticancer Res. 1994 Nov-Dec;14(6B):2743-6. Anticancer Res. 1994. PMID: 7532929

7

Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.

Schmitt UM, Stieber P, Hasholzner U, Pahl H, Hofmann K, Fateh-Moghadam A. Schmitt UM, et al. Among authors: hasholzner u. Eur J Clin Chem Clin Biochem. 1996 Aug;34(8):679-82. Eur J Clin Chem Clin Biochem. 1996. PMID: 8877347

8

Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.

Stieber P, Schmeller N, Schambeck C, Hofmann K, Reiter W, Hasholzner U, Fateh-Moghadam A. Stieber P, et al. Among authors: hasholzner u. Anticancer Res. 1996 Nov-Dec;16(6B):3793-8. Anticancer Res. 1996. PMID: 9042259

9

Significance of tumor marker determinations in the primary therapy of ovarian cancer.

Meier W, Baumgartner L, Stieber P, Hasholzner U, Fateh-Moghadam A. Meier W, et al. Among authors: hasholzner u. Anticancer Res. 1997 Jul-Aug;17(4B):2949-51. Anticancer Res. 1997. PMID: 9329572

10

Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.

Meier W, Stieber P, Hasholzner U, Baumgartner L, Fateh-Moghadam A. Meier W, et al. Among authors: hasholzner u. Anticancer Res. 1997 Jul-Aug;17(4B):2959-62. Anticancer Res. 1997. PMID: 9329575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters